NDC 50383-241-07 - Levetiracetam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 50383-241
Requested NDC: 50383-241-07
Package NDCs from labels: 50383-241-16, 50383-241-05, 50383-241-06, 50383-241-07, 50383-241-08, 50383-241-10, 50383-241-11
Manufacturer: Akorn | Akorn Operating Company LLC
Effective date: 2023-01-05
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Levetiracetam - Akorn \| Akorn Operating Company LLC	Akorn \| Akorn Operating Company LLC	2023-01-05	HUMAN PRESCRIPTION DRUG LABEL
Levetiracetam - REMEDYREPACK INC.	REMEDYREPACK INC.	2022-09-28	HUMAN PRESCRIPTION DRUG LABEL
Levetiracetam - Atlantic Biologicals Corps. \| Atlantic Biologicals Corps	Atlantic Biologicals Corps. \| Atlantic Biologicals Corps	2019-09-16	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50383-241-06	2024-07-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-08	2024-07-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-11	2024-07-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-16	2024-07-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-06	2024-01-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-08	2024-01-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-11	2024-01-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999
50383-241-16	2024-01-30	These highlights do not include all the information needed to use LEVETIRACETAM ORAL SOLUTION safely and effectively. See full prescribing information for LEVETIRACETAM ORAL SOLUTION. LEVETIRACETAM oral solution Initial U.S. Approval: 1999

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50383-241	LEVETIRACETAM SOLUTION [AKORN]	24	Legacy NDC	20230107_cb8aed34-2f3b-48b1-86ea-84b0d9e2b618.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50383-241-05	ML - Milliliter	50383-241	163f9342-466f-4f59-b291-b8c8437f0542	1	2017-04-05
50383-241-06	ML - Milliliter	50383-241	51543539-03f2-476a-b623-054e2a8cb3ec	1	2017-04-05
50383-241-16	ML - Milliliter	50383-241	c7b25572-cece-4a22-9883-7a3c3898a116	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
levetiracetam	ACTIVE INGREDIENT	44YRR34555	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
levetiracetam	ACTIVE MOIETY	44YRR34555	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
AMMONIUM GLYCYRRHIZATE	INACTIVE INGREDIENT	3VRD35U26C	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
MALTITOL	INACTIVE INGREDIENT	D65DG142WK	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
WATER	INACTIVE INGREDIENT	059QF0KO0R	LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.]	11
levetiracetam	ACTIVE INGREDIENT	44YRR34555	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
levetiracetam	ACTIVE MOIETY	44YRR34555	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
AMMONIUM GLYCYRRHIZATE	INACTIVE INGREDIENT	3VRD35U26C	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
MALTITOL	INACTIVE INGREDIENT	D65DG142WK	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LEVETIRACETAM SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 38 · 758 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Leader Eye Drops Redness Relief	GLYCERIN, NAPHAZOLINE HYDROCHLORIDE	Cardinal Health	aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a	2026-09-09	Warnings	Exact identifier unii: PDC6A3C0OX
Hemorrhoidal	GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM	Rite Aid Corporation	407c78ca-6fee-4ed6-b61b-711ec049c86e	2026-09-09	Warnings	Exact identifier unii: PDC6A3C0OX
Clear Eyes Nighttime	GLYCERIN	Prestige Brands Holdings, Inc.	af75e2f7-81dd-43e0-a390-b52bbfbebf62	2026-09-08	Warnings	Exact identifier unii: PDC6A3C0OX
Levetiracetam	LEVETIRACETAM	Cardinal Health 107, LLC	0348fec4-d919-4307-ac90-35360819bc00	2026-09-04	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Hemorrhoidal	GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM	CVS Pharmacy	3167c918-a7d3-46a1-a85b-64f9c22916f2	2026-09-04	Warnings	Exact identifier unii: PDC6A3C0OX
Levetiracetam	LEVETIRACETAM	REMEDYREPACK INC.	2d307850-0ed5-4f32-ac62-0e1e2fe27a7a	2026-09-03	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Levetiracetam ER	LEVETIRACETAM	REMEDYREPACK INC.	2d57f22f-fecc-466e-a444-87708c7c2f80	2026-08-27	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Levetiracetam	LEVETIRACETAM	Direct_Rx	5517b148-1eff-6421-e063-6394a90a9498	2026-08-27	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
KUGIG ALOE FOAMING INTIMATE WASH	INTIMATE CLEANSING FOAM	Hong Kong KangXing Centennial Management Limited	59f4d398-1186-a168-e063-6294a90ab44b	2026-08-26	Warnings	Exact identifier unii: 059QF0KO0R
LEVETIRACETAM	LEVETIRACETAM	REMEDYREPACK INC.	9bdef24b-c50e-4e6a-8650-59d78009f472	2026-08-26	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Sterile Water	WATER	REMEDYREPACK INC.	5dd5d148-6e23-41de-bff5-551b2aea9598	2026-08-24	Warnings, Adverse reactions	Exact identifier unii: 059QF0KO0R
LEVETIRACETAM	LEVETIRACETAM	REMEDYREPACK INC.	17969eda-4c85-40a0-9a94-7e4675adf910	2026-08-21	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Levetiracetam	LEVETIRACETAM	Ascend Laboratories, LLC	591dd9f1-3681-4b2f-b096-7536826e3648	2026-08-19	Warnings, Adverse reactions	Exact identifier unii: 44YRR34555
Leader Dry Eye Relief Eye Drops	GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400	CARDINAL HEALTH 110, LLC. DBA LEADER	2ded4bda-b3c3-4521-8701-5c8446fd148b	2026-08-17	Warnings	Exact identifier unii: PDC6A3C0OX
BM BM63 DROPS	CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN	BM Private Limited	59006d82-610a-2e08-e063-6394a90af1ed	2026-08-14	Warnings	Exact identifier unii: 059QF0KO0R
BM BM164 DROPS	ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM	BM Private Limited	5902770f-eb01-d099-e063-6394a90ad3eb	2026-08-14	Warnings	Exact identifier unii: PDC6A3C0OX
CVS Health Nausea Relief	SODIUM CITRATE DIHYDRATE	CVS PHARMACY,INC.	a5f9de6f-70d8-4bb0-8a5b-3dd120df2990	2026-08-14	Warnings	Exact identifier unii: B22547B95K
Adaptopath	ADENOSINUM CYCLOPHOSPHORICUM, ALPHA-LIPOICUM ACIDUM, ARGENTUM METALLICUM, AVENA SATIVA, CAPSICUM ANNUUM, CITRICUM ACIDUM, COENZYME A, CUPRUM METALLICUM, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYPOTHALAMUS (BOVINE), IODIUM, LEDUM PALUSTRE, MANGANUM ACETICUM, NADIDUM, NATRUM CARBONICUM, OLEUM MORRHUAE, PHOSPHORICUM ACIDUM, PICRICUM ACIDUM, RIBOFLAVINUM, SELENIUM METALLICUM SEPIA, SILICEA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), VANADIUM METALLICUM	Energetix Corporation	41234598-0cb5-41c2-bfbe-1c15ee9bf502	2026-08-11	Warnings	Exact identifier unii: XF417D3PSL
Aller-Chord A	ALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, BRYONIA (ALBA), CITRICUM ACIDUM, COUMARINUM, EUPHRASIA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, JUNIPERUS COMMUNIS, MUCOSA NASALIS SUIS, NATRUM SULPHURICUM, PHOSPHORUS, POTHOS FOETIDUS, PULSATILLA (VULGARIS), SOLIDAGO VIRGAUREA, SULPHUR, TANACETUM VULGARE, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE	Energetix Corporation	09e89c92-112d-4320-9df5-b9f938bb9095	2026-08-11	Warnings	Exact identifier unii: XF417D3PSL
Hepatic-Tone	CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALE	Energetix Corporation	d5f61f13-7e9f-4e46-8ad8-0336f36288df	2026-08-11	Warnings	Exact identifier unii: XF417D3PSL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.